Weight loss drug study for young adults with high blood pressure
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests if the weight loss medication tirzepatide can help young adults (18–40) with obesity and high blood pressure lower their blood pressure. It compares standard care to weight loss with tirzepatide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- Your body mass index (BMI) is 27 or higher
- You have been diagnosed with primary (essential) high blood pressure
- Your blood pressure is at least 135/85 but lower than 160/100 when measured without a doctor present
- You take no more than one blood pressure medication
- You do not have diabetes (type 1 or type 2) and are not using insulin or other injectable diabetes drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tirzepatide can improve heart and metabolic health in overweight or obese adults with congenital heart disease. It may offer a new treatment option for weight loss when lifestyle changes alone haven't worked.
This study tests whether a combination of exercise and a weight loss medication (tirzepatide) can help people with overweight or obesity lose weight and improve their health. It's a good fit if you are between 30 and 65, have a BMI of 30–40 (or 27–29.9 with a related health risk), and are generally healthy enough for medication and exercise.
This trial tests a medicine called tirzepatide, given as an injection, to see if it can improve daily function and symptoms in people with a weak heart (heart failure with reduced ejection fraction) who also have obesity. Tirzepatide works on two natural hormones to help with weight and may also improve heart health.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.